Anti Inflammatory News and Research

RSS

Study increases likelihood that MRI could be used as predictive technology to determine which patients should be placed on statin therapy for atherosclerosis

Using modified magnetic resonance imaging (MRI) techniques, researchers at Johns Hopkins have been able to detect the early benefits of a cholesterol-lowering medication much sooner than before.

11 Oct 2004

Progestin in hormone therapy could dramatically affect heart attack severity

“One type of hormone therapy limited heart muscle damage to only 5 percent while another resulted in permanent damage to 35 percent of muscle,” said J. Koudy Williams, Ph.D., lead investigator, from Wake Forest Baptist. “If we can learn more about this mechanism we might be able to identify better hormone therapies for postmenopausal women.”

10 Oct 2004

Researchers have found a starting point to establishing the genetic basis for sinus disease

In a three-year analysis of more than 10,500 genes, one-third of the human genome, researchers at Johns Hopkins have found a starting point to establishing the genetic basis for sinus disease and the growth of nasal polyps, illnesses not well understood despite their prevalence.

8 Oct 2004

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

The use of anti-inflammatory drugs to treat severe head injuries is actually dangerous

The use of anti-inflammatory drugs to treat patients with severe head injuries—common practice worldwide for the past 30 years—is actually dangerous and associated with around a 20% increase in death within two weeks of hospital admission, conclude authors of an international study in this week’s issue of THE LANCET.

8 Oct 2004

Canadian Rheumatology Association issues statement on Vioxx alternatives

The Canadian Rheumatology Association (CRA) has issued a statement to its 350 members and other interested parties, recommending alternative treatment considerations in the wake of the worldwide recall of Merck's rofecoxib, (Vioxx(R)) last week.

7 Oct 2004

Research continues to show the cardiovascular benefits of fish consumption or omega-3 fatty acids

USA-Peer-reviewed research continues to show the cardiovascular benefits of fish consumption or intake of long-chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFAs).

5 Oct 2004

U.S. healthcare industry reaction to the withdrawal of Vioxx from the world-wide market

NDCHealth has announced U.S. healthcare industry reaction to the Sept. 30 announcement by Merck & Co. that it was withdrawing its anti-arthritic medication Vioxx from the world-wide market.

5 Oct 2004

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

For the most of the past century, researchers have searched for a muscle-contraction-induced factor, which mediates some of the exercise effects in other tissues and organs such as the liver and adipose tissue.

5 Oct 2004

Natural alternatives to osteoarthritis drug

The recall of Vioxx should come as a major sign of the need to look for safer alternatives for osteoarthritis treatment, according to the Director of the Australian Centre for complementary Medicine Education and Research (ACCMER), Professor Stephen Myers.

5 Oct 2004

Reducing eosinophilic airway inflammation in severe asthma

Eosinophils are a type of white blood cell that constitute from 1 to 3 percent of the total white cell count. When foreign substances or infectious cells enter the body, lymphocytes and neutrophils attract eosinophils which release toxic substances that can destroy abnormal cells. Eosinophils function in allergic responses and in helping resist some infections.

4 Oct 2004

MHRA advice following withdrawal of Vioxx (rofecoxib)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice following the withdrawal of a widely-used pain-killer and anti-inflammatory drug Vioxx (rofecoxib).

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

Four or more glasses of red wine per week may reduce risk of prostate cancer by 50 percent

Drinking a glass of red wine a day may cut a man's risk of prostate cancer in half, and the protective effect appears to be strongest against the most aggressive forms of the disease

23 Sep 2004

Evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes

Endocrinologists from the University at Buffalo are providing one more link in the growing chain of evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes.

21 Sep 2004

HER-2 cell surface receptors tun on genes associated with carcinogenesis

Researchers at The University of Texas M. D. Anderson Cancer Center now have evidence that receptors found on tumors that were believed to function only on the surface of cells can actually switch on genes inside a cell's nucleus, thus promoting cancer development in two distinct ways.

21 Sep 2004

New anti-inflammatory strategy for cancer therapy

A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system’s inflammatory response into a cancer-killing outcome, is suggested in research findings by investigators at the University of California, San Diego (UCSD) School of Medicine.

20 Sep 2004

Anti Inflammatory News and Research

Study increases likelihood that MRI could be used as predictive technology to determine which patients should be placed on statin therapy for atherosclerosis

Progestin in hormone therapy could dramatically affect heart attack severity

Researchers have found a starting point to establishing the genetic basis for sinus disease

Aspirin might well be considered the top utility player in the medicine cabinet

The use of anti-inflammatory drugs to treat severe head injuries is actually dangerous

Canadian Rheumatology Association issues statement on Vioxx alternatives

Research continues to show the cardiovascular benefits of fish consumption or omega-3 fatty acids

U.S. healthcare industry reaction to the withdrawal of Vioxx from the world-wide market

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

Natural alternatives to osteoarthritis drug

Reducing eosinophilic airway inflammation in severe asthma

MHRA advice following withdrawal of Vioxx (rofecoxib)

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Four or more glasses of red wine per week may reduce risk of prostate cancer by 50 percent

Evidence pointing to chronic cellular inflammation as the precursor of heart disease and diabetes

HER-2 cell surface receptors tun on genes associated with carcinogenesis

New anti-inflammatory strategy for cancer therapy

Paintball injuries are sending more and more patients to the emergency room every year

Cancer drug effective at treating lupus

Genetically modified bacterium as remedy for intestinal diseases

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News